1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated clinical experience with ONC201 in previously-treated H3 K27M-mutant glioma patients
    Meeting Abstract

    Chi, A.; Arrillaga-Romany, I.; Gardner, S.; Wen, P.; Batchelor, T.; Hall, M.; Odia, Y.; Khatua, S.; Zaky, W.; McGovern, S.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Leptomeningeal melanoma metastasis presenting as intraventricular and subarachnoid hemorrhage
    Meeting Abstract

    Graham, M.; Jagannathan, R.; Rubens, E.; Wolchok, J.; Wu, S.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Intrathecal (IT) traztuzumab (T) for the treatment of leptomeningeal metastases (LM) in patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) cancer: A multicenter phase 1/2 study
    Meeting Abstract

    Kumthekar, P.; Gradishar, W.; Lin, N.; Pentsova, E.; Groves, M.; Jeyapalan, S.; Melisko, M.; Grimm, S.; Lassman, A. B.; Raizer, J.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of lung cancer patients with leptomeningeal metastases in the targeted therapy era
    Meeting Abstract

    Nevel, K.; Cowan, A.; Reiner, A.; Ogilvie, S.; Skakodub, A.; Distefano, N.; Pentsova, E.; Boire, A.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study of AG-881, an inhibitor of mutant IDH1 and IDH2: Results from the recurrent/progressive glioma population
    Meeting Abstract

    Mellinghoff, I.; Penas-Prado, M.; Peters, K.; Cloughesy, T.; Burris, H.; Maher, E.; Janku, F.; Cote, G.; De La Fuente, M.; Clarke, J.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Anti-CD27 agonist antibody varlilumab in combination with nivolumab for recurrent glioblastoma (rGBM): Phase 2 clinical trial results
    Meeting Abstract

    Reardon, D.; Kaley, T.; Iwamoto, F.; Baehring, J.; Subramaniam, D.; Rawls, T.; He, Y.; Keler, T.; Yellin, M.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Interim results of a phase II multicenter study of the conditionally replicative oncolytic adenovirus DNX-2401 with pembrolizumab (Keytruda) for recurrent glioblastoma: Captive study (Keynote-192)
    Meeting Abstract

    Zadeh, G.; Lang, F.; Daras, M.; Cloughesy, T.; Colman, H.; Ong, S.; Ramakrishna, R.; Vogelbaum, M.; Groves, M.; Nassiri, F.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Phase I study of AZD1775 with radiation therapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM) and evaluation of intratumoral drug distribution (IDD) in patients with recurrent GBM
    Meeting Abstract

    Alexander, B.; Supko, J.; Agar, N.; Ahluwalia, M.; Desai, A.; Dietrich, J.; Kaley, T.; Peereboom, D.; Takebe, N.; Desideri, S.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Safety and preliminary activity of PT2385, a first-in-class HIF2-alpha inhibitor, planned interim analysis of an open label, single-arm phase II study in patients with recurrent glioblastoma
    Meeting Abstract

    Strowd, R.; Ellingson, B.; Wen, P.; Ahluwalia, M.; Piotrowski, A.; Desai, A.; Clarke, J.; Lieberman, F.; Desideri, S.; Nabors, L. B.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Updated results of a phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM
    Meeting Abstract

    Lim, M.; Ye, X.; Nabors, L. B.; Piotrowski, A.; Ahluwalia, M.; Desai, A.; Walbert, T.; Fisher, J.; Desideri, S.; Sims, M.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save